Skip to content

Evaluation of Sinus Augmentation Bone Healing Using Autograft and Xenograft Compared to Xenograft Alone

Sinus Augmentation Healing With Autogenous and Xenograft Mix Compared to Xenograft Alone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06247098
Enrollment
10
Registered
2024-02-07
Start date
2024-09-01
Completion date
2028-05-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autogenous Bone Graft, Bone Substitute, Dental Implant, Maxillary Sinus Floor Augmentation

Keywords

Histology, Volume measurements, Radiographic

Brief summary

To evaluate bone healing at 4 months after lateral sinus augmentation with a 4:1 ratio of autologous bone and xenograft or xenograft alone. A radiographic volumetric, histomorphometric, and histologic analysis.

Interventions

PROCEDURESinus Lift augmentation

Randomised Sinus Lift augmentation either with Xenograft - Autogenous ratio 1:4 (test) or Xenograft alone (Control)

DEVICECone-beam computed tomography systems (CBCT)

An research only use of CBCT at visit 2 to review healing status.

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Clinical examiners, study surgeons, and subjects will not be blinded. Analysis of histomorphometric, histologic, and volumetric data will be completed by an external lab and will not be aware of what group the subjects were in.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of Tufts School of Dental Medicine (TUSDM) * Two stage sinus augmentations with \<5mm (Zinner, Small 2004) residual bone height in need of augmentation for implant placement * Full maxillary edentulism or Kennedy class I or III * 18 to 100 year old

Exclusion criteria

* Adults unable to consent (cognitively impaired adults) * Those who self-report as pregnant or breastfeeding * Wards of the state * Non-Viable neonates * Neonates of uncertain viability * \< 18 years of age * Refusal to participate * Prior medical condition causing complications in bone metabolism * Osteoporosis * History of/or current chemotherapy * History of/or current head and neck radiation * Current heavy smoking \> 10 cigarettes/day * Self-reported pregnancy or lactation * Previous history of sinus elevation procedure * Existing sinus pathology or pathology discovered at time of sinus augmentation or implant placement * Absence of autogenous donor site

Design outcomes

Primary

MeasureTime frameDescription
Histological analysis4 months from surgeryMineralized and non-mineralized tissue Remnant particles of biomaterial Inflammatory infiltrate

Secondary

MeasureTime frameDescription
Volumetric bone analysis 4 months post sinus augmentation4 months from surgerySinus volume calculation via CBCT analysis
Radiographic bone height gain at 4 months4 months post sinus augmentationResidual alveolar crest Final alveolar crest height at 4 months Initial height of graft immediately post graft placement Vertical bone material resorption

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLorenzo Mordini, DDS, MS

Tufts Univeristy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026